Skip to: Content
Skip to: Site Navigation
Skip to: Search
Newser - Current News - Breaking Stories

« Back to the grid | Next story »

Beefed-Up R&D Slows Drug Approval

Posted Jan 8, 08 5:45 PM CST in US,  Business,  Science & Health 

(Newser) – The FDA approved only 19 new drugs in 2007, the lowest total in 24 years. Bloomberg takes a look at the reasons. Some drug companies accuse the FDA of setting the bar higher for drug approvals, a charge the agency denies. Many, however, say the issue lies with big pharma devoting more attention to developing existing products than to creating new drugs.

"They got away from their core mission, which was to bring new medicines and new treatments to market,'' one expert says of the FDA. On the bright side, the drug companies are returning to a greater focus on new research, which should make next year a better one for new treatments.
Source: Bloomberg

0 comments | Print E-mail | Digg Seed this on Newsvine Add this link to Del.icio.us StumbleUpon

Related Newser Stories

  • Tiny Particles in Cosmetics Are Creating 'Nanophobes'

    Dec 4, 08 12:36 PM CST
    Tiny Particles in Cosmetics Are Creating 'Nanophobes' Though nanotechnology—relying on microscopic components—is common in many industries, scientists and consumers are worrying about the effects of nanoparticles in cosmetics, the New York Times reports. The fear is that the particles—50,000 times thinner than hair—can penetrate the skin and create havoc in our organs. Extensive safety tests haven’t been performed, and the FDA launched an ongoing nanomaterials study 2 years ago.

    More »

  • Quit-Smoking Drug Linked to Heart Trouble, Dizziness

    May 22, 08 7:39 CDT
    Quit-Smoking Drug Linked to Heart Trouble, Dizziness Pfizer smoking-cessation drug Chantix has been linked to nearly a thousand serious incidents in the last quarter of 2007, the Wall Street Journal reports. A report from a drug safety group found that some users of the drug—already linked to depression and suicide—suffered heart trouble, diabetes, or accidents caused by dizziness and confusion. More »

  • 8 Worrying Drug Side Effects

    Mar 7, 08 7:14 PM CST
    8 Worrying Drug Side Effects Despite rigorous testing, some drugs have side effects that only rear their ugly heads when introduced to the general population. Forbes catalogs some of the weirdest:

    1. Anti-smoking drug Chantix can cause insomnia and nightmares.
    2. Diet drug Alli can have unforeseen gastrointestinal side-effects; these can be counteracted by eating a low-fat diet, of all things.
    3. Mirapex, prescribed for Parkinson's and restless-leg-syndrome patients, can lead to compulsive-eating and gambling urges.
    More »

  • Puerto Rican Drug Plants Shipped Tainted Pills: FDA

    Feb 6, 08 1:38 PM CST
    Puerto Rican Drug Plants Shipped Tainted Pills: FDA The Caribbean island that produces 13 of the 20 best-selling drugs in the US has sold tainted pills and is struggling with quality control at its pharmaceutical plants, AP reports.  FDA inspections of 13 Puerto Rican plants between 2003 and 2007 revealed problems such as machinery pins left in drug bottles and foreign material embedded in tablets. More »

  • Tamiflu Will Carry Stronger Warning Labels

    Nov 28, 07 4:51 PM CST
    Tamiflu Will Carry Stronger Warning Labels The maker of flu drug Tamiflu said today it will accept recommendations by a government panel that it revise printed warnings about the medication's side effects. Labels already warn of possible psychiatric reactions, but the panel recommended noting that some people have died, the AP reports. Drugmaker Roche says flu alone can trigger problems such as delirium and wants the labels to make that clear as well. More »

GlaxoSmithKline had two drugs approved by the FDA in 2007 -- tied with one other company for the most.   (Getty Images)
Barbara Waks, 69, of Aventura, Florida, shows a container of pills she bought in Canada, where she estimates that she can save $200 a month on her drug bill.   (KRT Photos)
Food and Drug Administration (FDA) Commissioner Andrew von Eschenbach testifies on Capitol Hill in Washington, Tuesday, July 17, 2007, before a House Energy and Commerce subcommittee hearing on food...   (Associated Press)
The company logo of GlaxoSmithKline, is seen on the headquarters building in London, in this May 10, 2006 file photo. GlaxoSmithKline PLC is expected to release quarterly earnings on Wednesday, April...   (Associated Press)
« Prev« Prev | Next »Next » Slideshow
Our editors also recommend:

Related Threads

(1 of 2)

Tags

FDA • GlaxoSmithKline • drug safety • Novartis AG


Loading...

Today's Most Popular

[ Stories ]

Threads

Loading...
SPONSORED NEWS ARCHIVE

FDA approves DiamondClear oxygen scavenger technology.(New Products)(Food and... (Food & Beverage Packaging)

FDA issues new bioterrorism prior notice guidance.(WASHINGTON)(Food and Drug... (The Food Institute Report)

Hot Docs: Is FDA Shielding Drug Companies From Lawsuits?; Presidential Transitions. (U.S. News & World Report)

Sins of omission: drug companies twist the evidence about antidepressants.(Editorial) (Townsend Letter)

Joint FDA-EMEA effort seen yielding extra safety data for drug approval.(Biomarkers/International)(European... (Adverse Event Reporting News)

Off-label drug use needs strong oversight, researcher says.(Advertising/labeling) (Adverse Event Reporting News)

Outdated FDA clinical trial policies harming transplant drug research, AST,... (Transplant News)

National Restaurant Association Reacts to CDC Guidance on Chili Peppers (US Fed News Service, Including US State News)

Von Eschenbach does about-face, asks Congress for $275 million extra for inspections,... (Adverse Event Reporting News)

INFORMATION ABOUT SALMONELLA OUTBREAK (US Fed News Service, Including US State News)


Other Science & Health Stories